Turns doctor referrals into signed imaging reports across eight states, using its own AI to help radiologists handle more scans.
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 0
- ScaleMarket cap is above the global median
Turns doctor referrals into signed imaging reports across eight states, using its own AI to help radiologists handle more scans.
What this company is and how it runs — written from structure, not news.
RadNet runs outpatient imaging centers across eight states — Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas — converting physician referrals into MRI, CT, mammography, and other scans, but every image legally requires a radiologist's signature before it becomes a diagnostic report. Because radiologist licensure is state-specific, RadNet cannot relieve a backlog in Texas by pulling in a physician licensed only in New York, so the number of reports each center can produce each day is capped by however many licensed radiologists it can contract in that particular state. To stretch that headcount further, RadNet built DeepHealth, an AI division that pre-processes brain, breast, prostate, and pulmonary images to reduce the time each radiologist spends per scan — but the algorithms are trained entirely on scans flowing through RadNet's own centers, so if center volumes fall, the training signal thins and the AI loses accuracy, which in turn tightens the radiologist bottleneck it was built to relieve.
How does this company make money?
The company earns a fee each time a patient completes an imaging procedure — Medicare, Medicaid, and commercial insurers pay that fee, and the amount depends on which type of scan was performed and which insurer is paying. Separately, the DeepHealth division earns revenue by licensing its AI software to other radiology operations.
What makes this company hard to replace?
Referring physicians build habits and preferences around specific center locations and the particular radiologists who read their patients' scans — changing means rebuilding those relationships from scratch. Radiology practices that have integrated DeepHealth AI software into their daily workflow would need to retrain staff to use a different system. Insurance network contracts are also tied to specific facility locations and provider agreements, so switching centers can mean renegotiating those contracts or losing in-network status.
What limits this company?
The company can only produce as many signed reports per day as its radiologists can review — and each radiologist must be individually licensed in the specific state where the scan was taken. A radiologist licensed in New York cannot legally clear scans made in Texas. Because physician training takes years and cannot be sped up by spending more money, the company cannot simply buy its way out of this ceiling in any of its eight states.
What does this company depend on?
The company cannot operate without active imaging facility licenses from each of Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas. It also depends on radiologists who hold valid licenses in each of those states and are under contract to read scans. Working MRI, CT, and PET scanners — kept running through equipment maintenance agreements — are required at every center. Physician referral networks in each regional market keep patients coming in. Finally, Medicare and commercial insurance reimbursement approvals determine whether the company gets paid for completed procedures.
Who depends on this company?
Primary care doctors and specialists use the company's imaging results to diagnose conditions like cancer, neurological disorders, and musculoskeletal injuries — without those reports, treatment decisions stall. Hospital systems rely on the company's outpatient centers to handle overflow imaging demand; if the centers stopped, hospitals would face backlogs. Oncologists depend specifically on PET and CT scans from the network to stage cancers and decide on treatment plans.
How does this company scale?
Once DeepHealth's AI algorithms are built and validated, they can process a larger number of images without proportional added cost — software does not get tired or require a state medical license. Standardized scanning procedures can also be copied into new center locations relatively quickly. What does not scale easily is radiologist capacity: every new market the company enters requires finding and contracting physicians who are already licensed in that specific state, and that supply is limited by how many doctors complete radiology training each year.
What external forces can significantly affect this company?
Medicare sets the reimbursement rates for imaging procedures, and a cut to those rates would directly reduce what the company earns per scan. Each state sets its own rules for medical facility licenses, and those rules can change or tighten, blocking expansion or threatening existing centers. At the same time, an aging population is pushing imaging demand higher — which is good for volume but puts even more pressure on an already constrained radiologist workforce that medical schools cannot quickly expand.
Where is this company structurally vulnerable?
The AI gets better — and stays accurate — only as long as the company's centers keep producing large volumes of scans. If those volumes drop significantly, because Medicare cuts reimbursement rates, because a state pulls a facility license, or because too many radiologists leave, the AI gets less data to learn from and its accuracy falls. When the AI degrades, radiologists lose their main productivity tool, the bottleneck tightens, and the whole system slows down at once.
Price is read as structure — trend, levels, range, peak and volatility drawn on the chart. It does not predict where price goes next.
Sign in to view price data.
Sign in1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock behaving?
Three observations describe the present configuration: a high share of the trailing three years' weekly closes were higher than the prior week, the company has reported positive net income in each of the last five annual periods, and the book-value-increase-consistency composite over the trailing 5 years is elevated.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
The reported statements, read against the company's own industry.
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Net profit margin is positive while depreciation is a meaningful share of operating cash flow. The composition note: a non-trivial part of the earnings-to-cash bridge is depreciation specifically.
How is this stock valued?
Three observations describe the present configuration: the current close sits below the 40-week SMA (the conventional 'below 200-day SMA'), the company has reported positive net income in each of the last three annual periods, and operating cash flow exceeded net income in the most recent annual period.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Companies that share the same coordination system — how they create, deliver, or capture value.
Companies that share active interpretations — structural patterns currently present in both stocks.
CompanyGraph